Richard Esmond Beatson

7PUBLICATIONS

16CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 13, 2026

Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis.

|Aug 05, 2024

The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.

Jinhai Deng, Teng Pan, Dan Wang

|Oct 04, 2023

The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control.

Jinhai Deng, Teng Pan, Zaoqu Liu

|Jul 27, 2022

CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor Receptor.

Daniela Yordanova Achkova, Richard Esmond Beatson, John Maher

|Nov 27, 2021

Harnessing CD8<sup>+</sup>CD28<sup>-</sup> Regulatory T Cells as a Tool to Treat Autoimmune Disease.

Sabrina Ceeraz, Charlotte R Thompson, Richard Beatson

|Aug 07, 2021

Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.

Ester Pfeifer, Joy M Burchell, Francesco Dazzi

Pageof 2

Frequent Collaborators

Zaoqu Liu

Tony Ng

Rosalind Graham

Domenico Cozzetto

Ulla Mandel

Sarah Pinder

Joy M Burchell

Teng Pan

Petra Vlckova

Camila Araujo De Carvalho Gomes

Frequent Collaborators

Zaoqu Liu

Tony Ng

Rosalind Graham

Domenico Cozzetto